2.1. The Severe Cases of COVID-19 Are Accompanied by a Decrease in the Proportion of CD8+ T Cells, Mainly CD56−, and Changes in the CD56+ Fraction towards a Predominance of More Differentiated Cytotoxic Cells. The gene discussed is CD8A; the disease is COVID-19.